Notably, our methylation profiling revealed a striking difference in BRI3BP promoter methylation status between HCC and normal liver tissues, with significantly elevated methylation levels observed in malignant tissues (P = 0.000176; Fig. 6g). This evidence concerns the gene BRI3BP and hepatocellular carcinoma.